Dr Reddys Laboratories Share Price Today - Live Blog for October 08, 2025

There was no shift in the share price of Dr Reddys Laboratories Ltd, which stands at ₹1,234.40. This static period invites investors to consider the stock's fundamental strengths and weaknesses.

After a notable 0.22% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,235.55. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.04% upswing and is currently trading at ₹1,235.00, indicating strong market sentiment.

Dr Reddys Laboratories Ltd's share price has fallen by -0.04%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,234.95, and market participants are assessing the implications. The stock has a PE ratio of 18.3500, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.04% recently. As of now, this stock is actively trading at a current market price of ₹1,235.00 per share, attracting attention from investors.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.06%, reaching the current market price of ₹1,235.35. This development underscores the stock's growing popularity.

Dr Reddys Laboratories Ltd's share price has fallen by -0.11%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,235.30, and market participants are assessing the implications. The stock has a PE ratio of 18.3500, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.08% drop, and it's now trading at ₹1,236.65 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd stock price decreased by -0.12%, with the current market value at ₹1,237.80 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd shares experienced a -0.04% reduction, with the current market price at ₹1,238.40. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd's stock has surged by 0.02%, and it is currently trading at ₹1,238.25. Additionally, the stock maintains a PE ratio of 18.3500, while the industry PE is 34.4139.

Dr Reddys Laboratories Ltd experienced a substantial 0.07% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,237.90, making it an appealing option for investors.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.07%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,237.90 per share.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.20% increase. Presently, it is actively trading at ₹1,237.00.

After a significant 0.20% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,237.00 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Dr Reddys Laboratories Ltd shares saw a -0.08% decrease, reaching a current market price of ₹1,233.75. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 18.3500, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd shares experienced a -0.13% reduction, with the current market price at ₹1,235.55. Investors are carefully considering their positions and seeking insights into the stock's future performance.

With a -0.11% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,236.50. The stock is currently trading at a PE of 18.3500, while the industry PE is 34.4139, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd observed a remarkable 0.11% surge in its share price and is presently trading at ₹1,238.90. The increased investor interest is driving this surge.

The stock of Dr Reddys Laboratories Ltd suffered a -0.30% drop, and it's now trading at ₹1,237.50 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

The stock of Dr Reddys Laboratories Ltd suffered a -0.02% drop, and it's now trading at ₹1,241.20 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.12% increase and currently trading at ₹1,245.20 per share. This upward trajectory is turning heads in the market.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.12% boost, with the current market value at ₹1,245.20 per share. This surge has not gone unnoticed by investors.

The stock of Dr Reddys Laboratories Ltd is facing a -0.09% decline and is currently trading at ₹1,243.95 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Demonstrating a commendable 0.23% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,245.00. In terms of valuation, the stock maintains a PE ratio of 18.3500, while the industry PE ratio stands at 34.4139.

Dr Reddys Laboratories Ltd shares experienced a -0.38% reduction, with the current market price at ₹1,242.30. Investors are carefully considering their positions and seeking insights into the stock's future performance.

The share price of Dr Reddys Laboratories Ltd experienced a -0.18% slump and is currently trading at ₹1,245.55. While the stock maintains a PE ratio of 18.3500, the industry PE is 34.4139, raising questions about valuation.

The stock of Dr Reddys Laboratories Ltd suffered a -0.10% decline, and it currently trades at ₹1,247.80 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.